280,411,886 Equity Shares of Mankind Pharma Limited are subject to a Lock-Up Agreement Ending on 3-NOV-2023. These Equity Shares will be under lockup for 189 days starting from 28-APR-2023 to 3-NOV-2023.

Details:
Pursuant to Regulation 14 and Regulation 16 of the SEBI ICDR Regulations, an aggregate of 20% of the fully diluted post-Offer Equity share capital of our company that is 80,117,710 Equity shares held by our promoters, shall be considered as minimum promoters? contribution and locked-in for a period of 18 months from the date of allotment.

In terms of Regulation 17 of the SEBI ICDR Regulations, the entire pre-offer Equity share capital of our company will be locked-in for a period of six months from the date of allotment in the offer.